IOVA icon

Iovance Biotherapeutics
IOVA

Overview Fund Activity

300 hedge funds and large institutions have $798M invested in Iovance Biotherapeutics in 2025 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 99 increasing their positions, 91 reducing their positions, and 53 closing their positions.

Holders
300
Holders Change
+1
Holders Change %
+0.33%
% of All Funds
4.08%
Holding in Top 10
2
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-71.43%
% of All Funds
0.03%
New
58
Increased
99
Reduced
91
Closed
53
Calls
$7.88M
Puts
$6.57M
Net Calls
+$1.31M
Net Calls Change
+$8.85M

Top Buyers

1
ICM
1
Invenomic Capital Management
Massachusetts
$18.3M
2
LFCM
2
Long Focus Capital Management
Puerto Rico
$30.8M
3
UBS AM
3
UBS AM
Illinois
$19.2M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$11.7M
5
Bank of America
5
Bank of America
North Carolina
$10M

Top Sellers

1
PA
1
Perceptive Advisors
New York
$42.3M
2
ACA
2
Avoro Capital Advisors
New York
$0
3
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$6.43M
4
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$699K
5
SL
5
Siren LLC
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$92.5M 27,777,778 +243,438 +0.9%
MFM
2
MHR Fund Management
New York
$81.3M 24,417,103 – –
BlackRock
3
BlackRock
New York
$81M 24,314,578 +838,543 +4%
PA
4
Perceptive Advisors
New York
$42.3M 12,711,788 -9,400,478 -43%
State Street
5
State Street
Massachusetts
$36.8M 11,041,322 -1,207,960 -10%
LFCM
6
Long Focus Capital Management
Puerto Rico
$30.8M 9,250,055 +4,118,055 +80%
HRCM
7
Hood River Capital Management
Florida
$30.7M 9,216,040 +224,467 +2%
SCM
8
Soleus Capital Management
Connecticut
$25.9M 7,785,000 +1,225,000 +19%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$19.9M 5,968,298 +96,878 +2%
UBS AM
10
UBS AM
Illinois
$19.2M 5,777,344 +3,869,617 +203%
Goldman Sachs
11
Goldman Sachs
New York
$18.6M 5,571,902 +1,461,846 +36%
ICM
12
Invenomic Capital Management
Massachusetts
$18.3M 5,489,799 +5,489,799 New
Macquarie Group
13
Macquarie Group
Australia
$16M 4,791,235 +40,301 +0.8%
Principal Financial Group
14
Principal Financial Group
Iowa
$15.6M 4,694,122 +1,047,335 +29%
Artisan Partners
15
Artisan Partners
Wisconsin
$14.7M 4,407,713 -134,455 -3%
Morgan Stanley
16
Morgan Stanley
New York
$13.4M 4,018,374 +58,535 +1%
Renaissance Technologies
17
Renaissance Technologies
New York
$11.7M 3,511,400 +3,511,400 New
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$11.7M 3,506,108 +1,075,887 +44%
PAI
19
Palo Alto Investors
California
$10.7M 3,211,314 +169,629 +6%
Bank of America
20
Bank of America
North Carolina
$10M 3,017,185 +2,275,767 +307%
MB
21
MPM BioImpact
Massachusetts
$9.02M 2,708,582 +34,677 +1%
UBS Group
22
UBS Group
Switzerland
$8.31M 2,496,749 -207,720 -8%
T. Rowe Price Associates
23
T. Rowe Price Associates
Maryland
$8.01M 2,404,080 -224,021 -9%
6CM
24
683 Capital Management
New York
$7.99M 2,400,000 +983,986 +69%
Northern Trust
25
Northern Trust
Illinois
$7.8M 2,343,563 -71,244 -3%
1
2 3 4 5